Koh Ono

15.7k total citations · 1 hit paper
228 papers, 10.7k citations indexed

About

Koh Ono is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Surgery. According to data from OpenAlex, Koh Ono has authored 228 papers receiving a total of 10.7k indexed citations (citations by other indexed papers that have themselves been cited), including 107 papers in Cardiology and Cardiovascular Medicine, 91 papers in Molecular Biology and 54 papers in Surgery. Recurrent topics in Koh Ono's work include MicroRNA in disease regulation (27 papers), Atrial Fibrillation Management and Outcomes (24 papers) and Coronary Interventions and Diagnostics (22 papers). Koh Ono is often cited by papers focused on MicroRNA in disease regulation (27 papers), Atrial Fibrillation Management and Outcomes (24 papers) and Coronary Interventions and Diagnostics (22 papers). Koh Ono collaborates with scholars based in Japan, United States and China. Koh Ono's co-authors include Akira Matsumori, Shigetake Sasayama, Toru Kita, Takahiro Horie, Yutaka Furukawa, Koji Hasegawa, Tetsuo Shioi, Yasuhide Kuwabara, Takeshi Kimura and Jiahuai Han and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Circulation.

In The Last Decade

Koh Ono

214 papers receiving 10.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The p38 signal transduction pathway Activation and function

2000 1.4k citations Koh Ono et al. profile →

Peers

Countries citing papers authored by Koh Ono

Since Specialization

Citations

This map shows the geographic impact of Koh Ono's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Koh Ono with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Koh Ono more than expected).

Fields of papers citing papers by Koh Ono

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Koh Ono. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Koh Ono. The network helps show where Koh Ono may publish in the future.

Co-authorship network of co-authors of Koh Ono

This figure shows the co-authorship network connecting the top 25 collaborators of Koh Ono. A scholar is included among the top collaborators of Koh Ono based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Koh Ono. Koh Ono is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Nardilysin in adipocyte regulates insulin sensitivity via HIF1α and PPARγ 2025 ·Scientific Reports ·Shintaro Matsuda, Mikiko Ohno, (unknown), (unknown), (unknown), (unknown), Yoshinori Hiraoka, Takeshi Kimura, Koh Ono, Eiichiro Nishi	0
2	Efficacy and safety of Saireito (TJ-114) in patients with atrial fibrillation undergoing catheter ablation procedures: A randomized pilot study 2024 ·PLoS ONE ·Tetsuma Kawaji, Satoshi Shizuta, Hidenori Yaku, Kazuhisa Kaneda, (unknown), (unknown), (unknown), (unknown), (unknown), Kenji Nakatsuma, Masashi Kato, Takafumi Yokomatsu, Shinji Miki, Koh Ono, Takeshi Kimura	0
3	CRISPR-Cas9-guided amplification-free genomic diagnosis for familial hypercholesterolemia using nanopore sequencing 2024 ·PLoS ONE ·(unknown), Hiroki Shiomi, Yugo Yamashita, Satoshi Koyama, Takahiro Horie, Osamu Baba, Masahiro Kimura, Yasuhiro Nakashima, (unknown), Koji Hasegawa, Ayako Suzuki, Yutaka Suzuki, Takeshi Kimura, Koh Ono	5
4	GLP-1 receptor agonists: new game changing drugs in patients with heart failure with preserved ejection fraction and obesity 2023 ·European Heart Journal - Cardiovascular Pharmacotherapy ·Eri Kato, Basil S. Lewis, Koh Ono	2
5	VERVE-101: a promising CRISPR-based gene editing therapy that reduces LDL-C and PCSK9 levels in HeFH patients 2023 ·European Heart Journal - Cardiovascular Pharmacotherapy ·Takahiro Horie, Koh Ono	33
6	SGLT2 inhibitors in acute myocardial infarction: what can we learn from the DAPA-MI trial? More news from American Heart Association Scientific Meeting 2023 ·European Heart Journal - Cardiovascular Pharmacotherapy ·Eri Kato, Koh Ono, Basil S. Lewis	2
7	Incidence, clinical characteristics and long-term prognosis of postoperative symptomatic venous thromboembolism: a retrospective cohort study 2022 ·BMJ Open ·Chikashi Takeda, Yugo Yamashita, Masato Takeuchi, Hiroshi Yonekura, Li Dong, Miho Hamada, (unknown), Koh Ono, Koji Kawakami, Kazuhiko Fukuda, Takeshi Morimoto, Takeshi Kimura, Toshiyuki Mizota	4
8	Health improvement framework for actionable treatment planning using a surrogate Bayesian model 2021 ·Nature Communications ·Kazuki Nakamura, Ryosuke Kojima, Eiichiro Uchino, Koh Ono, Motoko Yanagita, Koichi Murashita, Ken Itoh, Shigeyuki Nakaji, Yasushi Okuno	8
9	Association between serum inflammatory biomarkers and atrial low voltage in patients with atrial fibrillation: A phase 1 FIB-MARK study 2021 ·IJC Heart & Vasculature ·Tetsuma Kawaji, Koh Ono, Naoya Sowa, (unknown), (unknown), Hidenori Yaku, Kenji Nakatsuma, Kazuhisa Kaneda, Masashi Kato, Takafumi Yokomatsu, Satoshi Shizuta, Shinji Miki, Takeshi Kimura	3
10	Homeobox A4 suppresses vascular remodeling by repressing YAP / TEAD transcriptional activity 2020 ·EMBO Reports ·Masahiro Kimura, Takahiro Horie, Osamu Baba, Yuya Ide, Shuhei Tsuji, (unknown), Toshimitsu Watanabe, Tomohiro Yamasaki, (unknown), (unknown), (unknown), Yasuhiro Nakashima, Takeshi Kimura, Koh Ono	22
11	Functional non‐coding RNAs in vascular diseases 2020 ·FEBS Journal ·Koh Ono, Takahiro Horie, Osamu Baba, Masahiro Kimura, Shuhei Tsuji, (unknown), (unknown), Takeshi Kimura	10
12	Effects of Metformin on Left Ventricular Size and Function in Hypertensive Patients with Type 2 Diabetes Mellitus: Results of a Randomized, Controlled, Multicenter, Phase IV Trial 2019 ·American Journal of Cardiovascular Drugs ·(unknown), Koh Ono, Hiromichi Wada, Noriko Satoh‐Asahara, (unknown), (unknown), Junichi Funada, Atsushi Ogo, Takahiro Horie, Masatoshi Fujita, Akira Shimatsu, Koji Hasegawa	8
13	Real-time surveillance of left atrial appendage thrombus during contrast computed tomography imaging for catheter ablation: THe Reliability of cOMputed tomography Beyond UltraSound in THROMBUS detection (THROMBUS) study 2018 ·Journal of Thrombosis and Thrombolysis ·Tetsuma Kawaji, (unknown), (unknown), (unknown), (unknown), (unknown), Koji Koizumi, Shotaro Kanao, Masashi Kato, Takafumi Yokomatsu, Satoshi Shizuta, Shinji Miki, Koh Ono, Kaori Togashi, Takeshi Kimura	9
14	Very long-term clinical outcomes after radiofrequency catheter ablation for atrial fibrillation: A large single-center experience 2017 ·International Journal of Cardiology ·Tetsuma Kawaji, Satoshi Shizuta, Takeshi Morimoto, (unknown), (unknown), Takashi Yoshizawa, Chihiro Ota, Naoaki Onishi, Yasuhiro Sasaki, (unknown), (unknown), Mamoru Hayano, Tetsushi Nakao, (unknown), Koji Goto, Takahiro Doi, Koh Ono, Takeshi Kimura	28
15	Abstract 17676: Microrna-33b Promotes Atherosclerotic Plaque Formation in Apoe-/- Mice 2017 ·Circulation ·Tomohiro Nishino, Takahiro Horie, Yasuhide Kuwabara, Tetsushi Nakao, Masataka Nishiga, Yuya Ide, Fumiko Nakazeki, Satoshi Koyama, Masahiro Kimura, Takeshi Kimura, Koh Ono	1
16	MSH2 Dysregulation Is Triggered by Proinflammatory Cytokine Stimulation and Is Associated with Liver Cancer Development 2016 ·Cancer Research ·Yuji Eso, Atsushi Takai, Tomonori Matsumoto, Tadashi Inuzuka, Takahiro Horie, Koh Ono, Shinji Üemoto, (unknown), Winfried Edelmann, Tsutomu Chiba, Hiroyuki Marusawa	24
17	microRNA-33 Regulates ApoE Lipidation and Amyloid-β Metabolism in the Brain 2015 ·Journal of Neuroscience ·Jaekwang Kim, Hyejin Yoon, Takahiro Horie, (unknown), Jessica L. Restivo, Noemí Rotllán, Cristina M. Ramírez, Philip B. Verghese, Masafumi Ihara, Hyang-Sook Hoe, Christine Esau, Carlos Fernández‐Hernando, David M. Holtzman, John R. Cirrito, Koh Ono, Jungsu Kim	102
18	Effect of Preinfarction Angina Pectoris on Long-term Survival in Patients With ST-Segment Elevation Myocardial Infarction Who Underwent Primary Percutaneous Coronary Intervention 2014 ·The American Journal of Cardiology ·Tomohiko Taniguchi, Hiroki Shiomi, Toshiaki Toyota, Takeshi Morimoto, Masaharu Akao, Kenji Nakatsuma, Koh Ono, Takeru Makiyama, Satoshi Shizuta, Yutaka Furukawa, Yoshihisa Nakagawa, Kenji Andò, Kazushige Kadota, Minoru Horie, Takeshi Kimura	13
19	Insulin-Like Growth Factor Axis (Insulin-Like Growth Factor-I/Insulin-Like Growth Factor-Binding Protein-3) as a Prognostic Predictor of Heart Failure: Association with Adiponectin 2010 ·European Journal of Heart Failure ·Shin Watanabe, Toshihiro Tamura, Koh Ono, Hisanori Horiuchi, Takeshi Kimura, Toru Kita, Yutaka Furukawa	47
20	Suppression of Cytokines and Nitric Oxide Production, and Protection Against Lethal Endotoxemia and Viral Myocarditis by a New NF-κB Inhibitor 2003 ·European Journal of Heart Failure ·Akira Matsumori, Youichi Nunokawa, Akira Yamaki, (unknown), Myung‐Woo Hwang, Tadashi Miyamoto, Masatake Hara, Ryosuke Nishio, (unknown), Koh Ono	38

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact